default author photo

Michael Hoelscher

Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine

SCHOLARLY PAPERS

3

DOWNLOADS

321

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

A Prospective, Randomised, Open Label Phase 2b Dose-Finding ​Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

Number of pages: 16 Posted: 10 Dec 2024
National Institute for Medical Research (NIMR), Radboud University Nijmegen - Radboud University Medical Center, National Institute for Medical Research (NIMR), Kibong’oto Infectious Diseases Hospital, Ifakara Health Institute, Ludwig Maximilian University of Munich (LMU), Aurum Institute, University of the Witwatersrand, Aurum Institute, National Institute for Medical Research (NIMR), Kibong’oto Infectious Diseases Hospital, Ifakara Health Institute, Ludwig Maximilian University of Munich (LMU), Ifakara Health Institute, Kibong’oto Infectious Diseases Hospital, Aurum Institute, University of St Andrews, Radboud University Nijmegen - Department of Lung Disease, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud Institute for Health Sciences, University College London, University College London, Radboud University Nijmegen - Department of Lung Disease, LigaChem Biosciences Inc, LigaChem Biosciences Inc, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Radboud University Nijmegen - Radboud Institute for Health Sciences, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine and Independent
Downloads 131 (554,631)

Abstract:

Loading...

Pulmonary tuberculosis, oxazolidinones, phase 2b, randomised clinical trial

2.

Early Depressing Effect on Abundancy and Diversity of Sputum Microbiome Followed by Recovery During Anti-Tuberculosis Treatment: A Multi-Regimen Analysis of the High-Rifampicin II- and Multi-Arm-Multi-Stage Clinical Trials

Number of pages: 47 Posted: 27 Jul 2022
University of St. Andrews - Division of Infection and Global Health, University of Mpumalanga - School of Biology and Environmental Sciences, NHS Foundation Trust - Department of Microbiology, University of St. Andrews - Division of Infection and Global Health, University of St. Andrews - Division of Infection and Global Health, National Institute for Medical Research (NIMR), Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Kilimanjaro Christian Medical University College - Kilimanjaro Christian Medical Centre, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Radboud University Nijmegen - Department of Lung Disease, University of St. Andrews - Division of Infection and Global Health, University of St. Andrews - Division of Infection and Global Health and Independent
Downloads 100 (689,572)

Abstract:

Loading...

Sputum microbiome surrogate for respiratory microbiome, anti-tuberculosis antibiotics, tuberculosis treatment, impact on microbiome, anti-tuberculosis drug development strategies.

3.

Birth Point-of-Care Test-and-Treat Reduces Early Clinical Events Among HIV-Positive Infants: A Cluster Randomized Trial

Number of pages: 32 Posted: 04 Oct 2023
Instituto Nacional de Saude, Mbeya Medical Research Center, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Instituto Nacional de Saúde., University of North Carolina (UNC) at Chapel Hill - National Institute of Health, Mbeya Medical Research Center, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, National Institute for Medical Research (NIMR), National Institute for Medical Research (NIMR), University of North Carolina (UNC) at Chapel Hill - National Institute of Health, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, affiliation not provided to SSRN, National Institute for Medical Research (NIMR), Clinton Health Access Initiative, affiliation not provided to SSRN, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Egas Moniz - Cooperativa de Ensino Superior CRL - Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), University of California, Los Angeles (UCLA), Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine and affiliation not provided to SSRN
Downloads 90 (742,061)

Abstract:

Loading...

HIV, early infant diagnosis, point-of-care testing, birth testing, Tanzania, Mozambique